Status:
RECRUITING
IMPact of Donor Heart Function on Recipient Outcomes - a prospectiVE Study to Increase the Utilization of Donor HEARTs
Lead Sponsor:
Vastra Gotaland Region
Conditions:
Heart Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
Severe heart failure is a diagnosis with a very poor prognosis. Heart transplantation is the best treatment for terminal heart failure but this type of treatment is limited by the number of available ...
Detailed Description
Severe heart failure is a diagnosis with a very poor prognosis where the 2-year mortality rate for serious heart failure is over 50%, which exceeds many cancer diagnoses. Despite advances in pharmacol...
Eligibility Criteria
Inclusion
- Patient who has been accepted for heart transplantation at the participating transplantation center
- The research subject has given written consent to participate in the study
- Aged 18 years or older
Exclusion
- • Mental inability, reluctance or language difficulties that result in difficulty understanding the meaning of study participation
- Another study, where the patient is included, which is not considered compatible with the current study.
Key Trial Info
Start Date :
April 5 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04393181
Start Date
April 5 2022
End Date
April 1 2027
Last Update
May 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahlgrenska University Hostpial
Gothenburg, Västra Götaland County, Sweden